NewEdge Advisors’s Monogram Orthopaedics MGRM Stock Holding History

NewEdge Advisors’s Portfolio MGRM Stock Details MGRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,396	Closed	-$8.2K	–	4329
2025 Q3	$8.2K	Hold	1,396	–	–	﹤0.01%	3388
2025 Q2	$4.03K	Hold	1,396	–	–	﹤0.01%	3466
2025 Q1	$4.1K	Sell	1,396 -706	-34%	-$1.87K	﹤0.01%	3350
2024 Q4	$4.98K	Hold	2,102	–	–	﹤0.01%	3236
2024 Q3	$5.57K	Hold	2,102	–	–	﹤0.01%	3138
2024 Q2	$4.52K	Hold	2,102	–	–	﹤0.01%	3126
2024 Q1	$5.13K	Buy	2,102 +706	+51%	+$2.08K	﹤0.01%	3129
2023 Q4	$4.8K	Hold	1,396	–	–	﹤0.01%	3129
2023 Q3	$3.63K	Hold	1,396	–	–	﹤0.01%	2895
2023 Q2	$5.56K	Buy	+1,396	New	+$7.22K	﹤0.01%	2778

NewEdge Advisors's MGRM Position: Q4 2025 in Review

NewEdge Advisors sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 1,396 shares — an estimated $8.2K sold.

NewEdge Advisors first reported a position in MGRM in Q2 2023 and held it in 10 quarters. The position peaked at $8.2K in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

NewEdge Advisors reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
NewEdge Advisors sold 1,396 Monogram Orthopaedics shares in Q4 2025, an estimated $8.2K.
NewEdge Advisors first reported a position in Monogram Orthopaedics in Q2 2023 and held it in 10 quarters.
NewEdge Advisors's Monogram Orthopaedics position peaked at $8.2K in Q3 2025.
0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on NewEdge Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.